Michel Bouvier

Michel Bouvier is the CEO of Institut de recherche en immunologie et en cancérologie (IRIC). Michel has also previously served as the directeur of Réseau Québécois en Recherche sur les Médicaments (RQRM) and as the chairman of Université de Montréal's Départment of Biochemistry.

Bouvier has dedicated their career to research in the fields of immunology and cancer. Their work has helped to improve our understanding of these diseases and has led to the development of new treatments. Michel is widely respected in the scientific community, and their work has earned him numerous awards and honors.

Michel Bouvier completed a B.Sc. and Ph.D. in Biochemistry and Neuroscience at Université de Montréal before doing postdoctoral work as a molecular pharmacology fellow at Duke University.

Some individuals on their team include Marc Therrien - Scientific Director, Sébastien Roy - Assistant General Director, Operations & Finances.